ClinicalTrials.gg

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

ResMed clinical trials

The registry lists 120 studies whose lead sponsor is ResMed or one of 2 companies grouped under it. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 27, 2026.

Get an email when these change. Save the ResMed studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
79
Terminated
11
Not yet recruiting
9
Status unknown
7
Recruiting
6
Withdrawn
5

Phase

Phase 4
2
Phase 2
1
Phase 3
1
Phase 1
1

Where

United States
36
Australia
35
Germany
23
France
11
United Kingdom
8
Belgium
4

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to ResMed.

  • ResMed
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    105 studies
  • Noctrix Health, Inc.
    Acquired — became part of ResMed, Jun 1, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →
  • Ectosense NV
    Acquired — became part of ResMed, Oct 1, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →

Focus areas

Conditions ResMed leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 120. Browse all 120 →